Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Clinical trial NCT01737814 · COMPLETED
Trial details
- NCT number
- NCT01737814
- Sponsor
- Mast Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2016-02-01
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.